Zai Lab partners with Amgen for combination cancer therapy trial
Go back to Zai Lab partners with Amgen for combination cancer therapy trial| Amgen Inc (NASDAQ: AMGN) | Delayed: 347.01 +2.29 (0.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $344.72 | 52 Week High | $176.85 | |||
| Open | $348.31 | 52 Week Low | $133.64 | |||
| Day High | $349.40 | P/E | 52.26 | |||
| Day Low | $345.49 | EPS | $6.64 | |||
| Volume | 2,203,139 | |||||
| (NASDAQ: ZLAB) | Delayed: 18.49 +0.01 (0.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.48 | 52 Week High | $ | |||
| Open | $18.47 | 52 Week Low | $ | |||
| Day High | $18.74 | P/E | N/A | |||
| Day Low | $18.11 | EPS | $ | |||
| Volume | 1,669,916 | |||||
